Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 22,067 shares at $123.16 ($2.7M) on 2016-08-05, disclosed to the SEC on 2016-08-09.
Open-market sale of $2.7M LGND by VP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.16 | 4,295 | $529K | 19.5% |
| 2 | $123.16 | 5,688 | $701K | 25.8% |
| 3 | $123.16 | 12,084 | $1.5M | 54.8% |
| Total | $123.16 avg | 22,067 | $2.7M | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |